ctrl K

Watchlist Price Alert

Day One Biopharmaceutical... (DAWN)

NASDAQ: DAWN · Real-Time Price · USD

6.49

-0.15 (-2.26%)

At close: Jun 17, 2025, 10:45 AM

Day One Biopharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	124.97M	230.78M	85.26M	284.31M	43.73M	27.33M
Short-Term Investments	406.75M	135.56M	257.01M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	121K	214K	469K	169K	107K	n/a
Receivables	13.88M	n/a	n/a	n/a	n/a	n/a
Inventory	3.32M	n/a	n/a	n/a	n/a	n/a
Other Current Assets	4.37M	2.35M	1.01M	1.01M	1.26M	n/a
Total Current Assets	562.33M	375.27M	347.87M	289.37M	45.07M	27.34M
Property-Plant & Equipment	4.71M	560K	719K	284K	483K	n/a
Goodwill & Intangibles	15.63M	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	20.46M	774K	1.19M	453K	590K	n/a
Total Assets	582.79M	376.05M	349.06M	289.82M	45.66M	27.34M
Account Payables	3.26M	2.58M	260K	1.74M	202K	69K
Deferred Revenue	1.55M	n/a	n/a	6.61M	1.57M	n/a
Short-Term Debt	10K	n/a	405K	204K	n/a	n/a
Other Current Liabilities	68.64M	1.04M	9.42M	-100K	27K	1.49M
Total Current Liabilities	73.45M	29.51M	16.61M	8.66M	2M	2.02M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	761K	n/a	n/a	n/a	91.96M	30.5M
Total Long-Term Liabilities	6.59M	n/a	408K	16K	92.17M	30.5M
Total Liabilities	80.04M	29.51M	17.02M	8.67M	94.16M	32.52M
Total Debt	2.6M	408K	813K	220K	402K	n/a
Common Stock	10K	9K	7K	6K	2M	2M
Retained Earnings	-554.08M	-458.58M	-269.67M	-127.49M	-56.84M	-12.78M
Comprehensive Income	84K	9K	-71K	0.00	637.00	111.00
Shareholders Equity	502.75M	346.54M	-269.67M	-127.49M	-54.2M	-10.67M
Total Investments	406.75M	135.56M	257.01M	n/a	n/a	n/a